CD4+ T cells are critical for sustaining CD8+ cytotoxic T cell immunity [16], and our results here suggest that closer attention should be paid to CD4+ T cell immune responses following immunotherapy administration, particularly in the context of obesity. The gene discussed is CD8A; the disease is obesity disorder.